LMP-1 and Nasopharyngeal Carcinoma (NPC)
Abstract
Keywords
H2O2, LMP-1; nasopharyngeal carcinoma, nicotine, nitrosamine
Kaynakça
- Cho WC. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Molecular Cancer. 2007;6:1-9.
- Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5: 423-8.
- Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, Nakanishi S, Tsuji A, Ito M. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Letters. 2013;337:1-7.
- Young LS & Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.
- Du CW, Wen BG, Li DR, Lin YC, Zheng YW, Chen L, Chen JY, Lin W, Wu MY.Latent membrane protein-1 of Epstein-Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell. Exp Oncol. 2005;27:267-72.
- Budiningrum AI, Rofi’i A, Suharjono S, Fatchiyah F. PARP-1 expression against Epstein-Barr virus LMP-1 and BZLF-1 in undifferentiated nasopharyngeal carcinoma. J Exp Integr Med. 2013;3:299-304.
- Lassoued S, Gargouri B, El Feki Ael F, Attia H, van Pelt J. Transcription of the Epstein-Barr Virus lytic cycle activator BZLF-1 during oxidative stress induction. Biol Trace Elem Res. 2010;137:13-22.
- Rofi’i A, Fatchiyah F, Rahayu P, Muhyi R, Sumitro SB. Reactive oxygen species, NFᴋB, and p53 levels in tissue of undifferentiated nasopharyngeal carcinoma. Oxid Antioxid Med Sci. 2013;2:143-7.
- Dood LE, Sengupta S, Chen I-H, den Bonn JA, Cheng Y-J, Westra W, Newton MA, Mittl BF, McShane L, Chen C-J, Ahlquist P, Hildesheim A. Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:2216-25.
- Yu MC & Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-9.
